<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 30-year-old woman with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) presented with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Administration of <z:chebi fb="0" ids="32301">warfarin potassium</z:chebi>, without concomitant <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> administration, significantly improved <z:hpo ids='HP_0000001'>all</z:hpo> of these symptoms along with a decrease in the titers of antiCL-beta2-GP-I antibodies and a shortening of prolonged APTT </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in this patient could have been evoked by <z:chebi fb="6" ids="28384">vitamin-K</z:chebi>-dependent coagulation factors or plasma proteins which are assumed to undergo conformational changes exposing cryptic <z:chebi fb="0" ids="53000">epitopes</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>This case report provides clues to the mechanisms underlying the production of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in patients with PAPS </plain></SENT>
</text></document>